WO2008077201A1 - Naphthalan oil-based composition - Google Patents

Naphthalan oil-based composition Download PDF

Info

Publication number
WO2008077201A1
WO2008077201A1 PCT/AZ2006/000009 AZ2006000009W WO2008077201A1 WO 2008077201 A1 WO2008077201 A1 WO 2008077201A1 AZ 2006000009 W AZ2006000009 W AZ 2006000009W WO 2008077201 A1 WO2008077201 A1 WO 2008077201A1
Authority
WO
WIPO (PCT)
Prior art keywords
naphthalan
oil
white
extracts
mass
Prior art date
Application number
PCT/AZ2006/000009
Other languages
French (fr)
Russian (ru)
Inventor
Mushvig Hasan Oglu Mirzoyev
Adil Mustafa Oglu Agaev
Ashraf Aliabbas Oglu Jafarov
Original Assignee
Mushvig Hasan Oglu Mirzoyev
Adil Mustafa Oglu Agaev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mushvig Hasan Oglu Mirzoyev, Adil Mustafa Oglu Agaev filed Critical Mushvig Hasan Oglu Mirzoyev
Priority to PCT/AZ2006/000009 priority Critical patent/WO2008077201A1/en
Publication of WO2008077201A1 publication Critical patent/WO2008077201A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Definitions

  • the invention relates to the creation of tools for the treatment and prevention of skin diseases and inflammatory diseases of the musculoskeletal system, namely, medicinal compositions based on naphthalan oil.
  • Preparations based on naphthalan oil are divided into emulsions (liniment), suppositories, pastes and ointments.
  • Ointment is known on the basis of refined naphthalan oil, to which 1 part of boric acid, zinc oxide and wheat starch are added, the rest is naphthalan oil (9 parts). (one)
  • a known composition based on naphthalan oil and water (4) A known composition based on naphthalan oil and water (4).
  • a disadvantage of the known formulations is that with prolonged use, burning begins at the site of application of the drug, dry skin, folliculitis and a persistent oil smell.
  • the prototype of the claimed emulsion composition is liniment based on black refined Naftalan oil and emulsion base.
  • the prototype for the composition of the ointment is a composition based on refined naphthalan oil containing paraffin and petrolatum.
  • the objective of the invention is the creation of soft, without a specific oil smell, non-irritating skin compositions for the prevention and local treatment of inflammatory diseases, both skin and joints and muscles.
  • the problem is solved in that the composition based on naphthalan oil containing an emulsion base, according to the invention, contains dearomatized white naphthalan as naphthalan oil, and contains Ti, or T 2 emulsifier as an emulsion base, and additionally, aqueous extracts of medicinal plants in the following ratio of components mass%: dearomatized white naphthalan - 12.5-30; emulsifier - 3-7; water extracts of medicinal plants - the rest;
  • a composition based on naphthalan oil containing paraffin according to the invention contains dearomatized white naphthalan as naphthalan oil, and additionally, white medical vaseline, oil extracts of medicinal plants, in the following ratio of components, mass.
  • % dearomatized white naphthalan-15-45; oil extracts-2-6; paraffin-15-20, medical white petrolatum, the rest, while the medicinal plants for the water or oil extracts of the composition contain chamomile and / or geranium, and / or eucalyptus, and / or clove, and / or lavender, and / or a rose, and / or diphazium, and / or myrtle, and / or primrose.
  • the essence of the invention lies in the fact that medicinal compositions for the local treatment of inflammatory diseases of both joints and muscles and the epidermis, by introducing new ingredients within the claimed limits, their quantitative ratio ensures the activation of metabolic processes in the skin, normalizes blood circulation, and eliminates stagnation in areas of inflammation, accelerate the penetration of active therapeutic substances into the affected areas, while not causing an allergic background.
  • compositions have bactericidal properties.
  • Medicinal plants selected as ingredients of the proposed compositions were subjected to extraction in oil and in water.
  • Water extracts were prepared by four decantation with distilled water at a temperature not exceeding 60 0 C with constant stirring for 4 hours. If the total amount of plant extracts was introduced into the composition, then they were taken in equal amounts with constant stirring for 2 hours until a homogeneous mass was obtained. Oil extracts were prepared as follows: Dried medicinal plants were crushed and mixed in equal amounts, then the resulting mixture was poured with refined vegetable oil taken in a ratio of 1:10 and heated to 60 0 C with constant stirring for 2 hours. Then this mixture is insisted for 3 to 5 days in a dark, cool place. After that, the resulting oil extract is subjected filtering to remove suspended particles.
  • Dearomatized white naphthalan is a non-tarred, colorless oily fraction of naphthalan oil, consisting mainly of polycyclic naphthenic hydrocarbons. This oil fraction is used as a basis in compositions for the treatment and prevention of inflammatory processes of skin diseases and diseases of joints and muscles.
  • Emulsifier brand Ti (FS 42-1596-81), or T 2 (according to TU 18-17 / 05-67) which are introduced into the composition to create a strong and stable emulsion.
  • This product does not cause side effects on human skin, with T 1 HT 2 ,
  • the proposed composition can be used for a long time.
  • the lower limit When the lower limit is introduced into the composition of the emulsifier composition, it results in a heterogeneous and unstable emulsion, and above the claimed limit it is not advisable, since this ingredient is overused.
  • the below-mentioned limit is introduced into the composition of the oil extract, the consistency of the ointment deteriorates due to an increase in the paraffin content (the ointment becomes not elastic and hardens quickly), and when its content increases, it also leads to a deterioration in the overall composition, since the ointment becomes more fluid.
  • Medical Vaseline (GOST 3582-84) is introduced into the composition as a filler.
  • the positive effect is that in addition to the fact that the proposed composition can be used for massage, it can also be used for cosmetic purposes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The inventive naphthalan oil-based composition comprises a dearomatised white naphthalan in the form of a naphthalan oil, an emulsifier T1 or T2 in the form of an emulsion base and, in addition, aqueous extracts of medicinal plants at the following component ratio (in mass%): 12.5-30.0 mass% dearomatised white naphthalan and 3.0-7.0 mass% emulsifier, the aqueous extracts of medicinal plants being the rest. The inventive nafthalan oil-based paraffin-containing composition comprises the dearomatised white naphthalan, in addition, white petroleum jelly and oil extracts of medicinal plants at the following component ratio (in mass%): 15.0-45.0 mass% dearomatised white naphthalan, 2.0-6.0 mass% oil extracts and 15.0-20.0 mass% paraffin, the white petroleum jelly being the rest, wherein the compositions contain camomile and/or geranium and/or eucaliptus and/or clove and/or lavender and/or rose and/or diphasium and/ or myrthle and/or primose in the form of medicinal plants for the aqueous and oil extracts.

Description

КОМПОЗИЦИЯ НА ОСНОВЕ НАФТАЛАНСКОЙ НЕФТИ COMPOSITION BASED ON NAFTALAN OIL
Изобретение относится к созданию средств для лечения и профилактики кожных заболеваний и воспалительных заболеваний опорно-двигательного аппарата, а именно к лекарственным композициям на основе нафталанской нефти.The invention relates to the creation of tools for the treatment and prevention of skin diseases and inflammatory diseases of the musculoskeletal system, namely, medicinal compositions based on naphthalan oil.
Препараты на основе нафталанской нефти делятся на эмульсии (линименты), свечи, пасты и мази.Preparations based on naphthalan oil are divided into emulsions (liniment), suppositories, pastes and ointments.
Известна на основе рафинированной нафталанской нефти мазь, в состав которой дополнительно вводят 1 часть борной кислоты, окись цинка и пшеничный крахмал , остальное нафталанская нефть (9чacтeй). (1)Ointment is known on the basis of refined naphthalan oil, to which 1 part of boric acid, zinc oxide and wheat starch are added, the rest is naphthalan oil (9 parts). (one)
Известна лекарственная композиция на основе рафинированной черной нафталанской нефти (70 частей) с парафином (18 частей) и петролатумом (12 частей). (2)Known pharmaceutical composition based on refined black naphthalan oil (70 parts) with paraffin (18 parts) and petrolatum (12 parts). (2)
Известна противозудная, бактерицидная, ранозаживляющая эмульсия на основе нафталанской нефти с эмульсионной основой взятых в соотношении 1:10.(3)Known antipruritic, bactericidal, wound healing emulsion based on Naftalan oil with an emulsion base taken in a ratio of 1:10. (3)
Известна композиция на основе нафталанской нефти и воды (4). Недостатком известных составов является то, что при длительном применении начинается жжение на месте нанесения препарата, сухость кожи, фолликулит и устойчивый нефтяной запах.A known composition based on naphthalan oil and water (4). A disadvantage of the known formulations is that with prolonged use, burning begins at the site of application of the drug, dry skin, folliculitis and a persistent oil smell.
Прототипом к заявляемому эмульсионному составу является линимент на основе черной рафинированной нафталанской нефти и эмульсионной основы. Прототипом к составу мази является композиция на основе рафинированной нафталанской нефти, содержащая парафин и петролатум.The prototype of the claimed emulsion composition is liniment based on black refined Naftalan oil and emulsion base. The prototype for the composition of the ointment is a composition based on refined naphthalan oil containing paraffin and petrolatum.
Задачей предлагаемого изобретения является создание мягких, без специфического нефтяного запаха, не раздражающих кожу композиций для профилактики и локального лечения воспалительных заболеваний, как кожных, так и суставов и мышц. Поставленная задача решается тем, что композиция на основе нафталанской нефти, содержащая эмульсионную основу, согласно изобретению, в качестве нафталанской нефти содержит деароматизированный белый нафталан, а в качестве эмульсионной основы содержит эмульгатор Ti, или T2, и дополнительно, водные экстракты лекарственных растений при следующем соотношении компонентов, мacc.%: деароматизированный белый нафталан - 12,5-30; эмульгатор - 3-7; водные экстракты лекарственных растений — остальное; Композиция на основе нафталанской нефти, содержащая парафин, согласно изобретению, в качестве нафталанской нефти содержит деароматизированный белый нафталан, и дополнительно, вазелин белый медицинский, масляные экстракты лекарственных растений, при следующем соотношении компонентов, масс. % : деароматизированный белый нафталан- 15-45; масляные экcтpaкты-2-6; парафин- 15-20, вазелин медицинский белый остальное, при этом в качестве лекарственных растений для водного или масляного экстрактов композиции содержат ромашку и/или герань, и/или эвкалипт, и/или гвоздику, и/или лаванду, и/или розу, и/или дифазиум, и/или мирт, и/или примулу.The objective of the invention is the creation of soft, without a specific oil smell, non-irritating skin compositions for the prevention and local treatment of inflammatory diseases, both skin and joints and muscles. The problem is solved in that the composition based on naphthalan oil containing an emulsion base, according to the invention, contains dearomatized white naphthalan as naphthalan oil, and contains Ti, or T 2 emulsifier as an emulsion base, and additionally, aqueous extracts of medicinal plants in the following ratio of components mass%: dearomatized white naphthalan - 12.5-30; emulsifier - 3-7; water extracts of medicinal plants - the rest; A composition based on naphthalan oil containing paraffin according to the invention contains dearomatized white naphthalan as naphthalan oil, and additionally, white medical vaseline, oil extracts of medicinal plants, in the following ratio of components, mass. %: dearomatized white naphthalan-15-45; oil extracts-2-6; paraffin-15-20, medical white petrolatum, the rest, while the medicinal plants for the water or oil extracts of the composition contain chamomile and / or geranium, and / or eucalyptus, and / or clove, and / or lavender, and / or a rose, and / or diphazium, and / or myrtle, and / or primrose.
Сущность предлагаемого изобретения заключается в том, что лекарственные композиции для локального лечения воспалительных заболеваний как суставов и мышц, так и эпидермиса, путем введения в заявляемых пределах в состав новых ингредиентов, их количественное соотношение обеспечивают активацию обменных процессов в коже, нормализуют кровоснабжение, ликвидируют застойные явления в зонах воспаления, ускоряют проникновение активных лечебных веществ в пораженные участки, при этом не вызывают аллергического фона.The essence of the invention lies in the fact that medicinal compositions for the local treatment of inflammatory diseases of both joints and muscles and the epidermis, by introducing new ingredients within the claimed limits, their quantitative ratio ensures the activation of metabolic processes in the skin, normalizes blood circulation, and eliminates stagnation in areas of inflammation, accelerate the penetration of active therapeutic substances into the affected areas, while not causing an allergic background.
Кроме того, все предлагаемые композиции обладают бактерицидными свойствами.In addition, all proposed compositions have bactericidal properties.
Лекарственные растения выбранные в качестве ингредиентов предлагаемых композиций подвергались экстракции в масле и в воде.Medicinal plants selected as ingredients of the proposed compositions were subjected to extraction in oil and in water.
Водные экстракты готовились четырехкратным декантированием дистиллированной водой при температуре не выше 600C при постоянном перемешивании в течении 4 часов. Если в состав вводили суммарное количество растительных экстрактов, то их брали в равных количествах при постоянном перемешивании в течение 2 часов до получения однородной массы. Масляные экстракты готовились следующим образом: Высушенные лекарственные растения измельчают и в равных количествах смешивают, затем полученную смесь заливают рафинированным растительным маслом взятых в соотношении 1:10 и при постоянном перемешивании нагревают до 600C в течение 2 часов. Затем эту смесь настаивают в течение от 3 до 5 суток в темном прохладном месте. После этого полученный масляной экстракт подвергают фильтрации с целью удаления взвешенных частиц.Water extracts were prepared by four decantation with distilled water at a temperature not exceeding 60 0 C with constant stirring for 4 hours. If the total amount of plant extracts was introduced into the composition, then they were taken in equal amounts with constant stirring for 2 hours until a homogeneous mass was obtained. Oil extracts were prepared as follows: Dried medicinal plants were crushed and mixed in equal amounts, then the resulting mixture was poured with refined vegetable oil taken in a ratio of 1:10 and heated to 60 0 C with constant stirring for 2 hours. Then this mixture is insisted for 3 to 5 days in a dark, cool place. After that, the resulting oil extract is subjected filtering to remove suspended particles.
В качестве растительного масла можно использовать хлопковое, подсолнечное, кукурузное, оливковое и т.д.As vegetable oil, you can use cottonseed, sunflower, corn, olive, etc.
Деароматизированный белый нафталан представляет собой обессмоленную бесцветную масляную фракцию нафталанской нефти, состоящую в основном из полициклических нафтеновых углеводородов. Эту масляную фракцию используют как основу в композициях для лечения и профилактики воспалительных процессов кожных заболеваний и заболеваний суставов и мышц.Dearomatized white naphthalan is a non-tarred, colorless oily fraction of naphthalan oil, consisting mainly of polycyclic naphthenic hydrocarbons. This oil fraction is used as a basis in compositions for the treatment and prevention of inflammatory processes of skin diseases and diseases of joints and muscles.
Эмульгатор марки Ti (ФС 42-1596-81),или T2 (по ТУ 18-17/05-67) которые вводятся в состав для создания прочной и устойчивой эмульсии. Данный продукт не вызывает побочных явлений на коже человека, причем T1H-T2 ,Emulsifier brand Ti (FS 42-1596-81), or T 2 (according to TU 18-17 / 05-67) which are introduced into the composition to create a strong and stable emulsion. This product does not cause side effects on human skin, with T 1 HT 2 ,
Как показали исследования, введение в композицию на основе нафталанской нефти водных или масляных экстрактов лекарственных растений усиливает эффект проницаемости биологически активных веществ в ткани человека, тем самым способствуют уменьшению воспалительных процессов, не раздражают кожный покров воспаленного участка и способствуют пролонгированию лечебного действия композиции в целом.As studies have shown, the introduction of water or oil extracts of medicinal plants into a composition based on naphthalan oil enhances the effect of the permeability of biologically active substances into human tissues, thereby reducing inflammatory processes, not irritating the skin of the inflamed area and prolonging the therapeutic effect of the composition as a whole.
Предлагаемые композиции можно применять продолжительное время.The proposed composition can be used for a long time.
При введении деароматизированного белого нафталана в состав композиции нижезаявляемого предела не дает желаемого эффекта, а увеличение нецелесообразно, так как происходит перерасход его.With the introduction of dearomatized white naphthalan into the composition of the below-stated limit, it does not give the desired effect, and an increase is inappropriate, since it is overused.
При введении в состав композиции эмульгатора нижезаявляемого предела приводит к получению неоднородной и не стойкой эмульсии, а выше заявляемого предела не целесообразно, так как происходит перерасход данного ингредиента. При введении в состав композиции масляного экстракта нижезаявляемого предела ухудшается консистенция мази за счет увеличения содержания парафина ( мазь становится не эластичная и быстро твердеет), а при увеличении ее содержания также приводит к ухудшению общего состава композиции , так как мазь становится более текучей. Вазелин медицинский (ГОСТ 3582-84) вводят в состав как наполнитель.When the lower limit is introduced into the composition of the emulsifier composition, it results in a heterogeneous and unstable emulsion, and above the claimed limit it is not advisable, since this ingredient is overused. When the below-mentioned limit is introduced into the composition of the oil extract, the consistency of the ointment deteriorates due to an increase in the paraffin content (the ointment becomes not elastic and hardens quickly), and when its content increases, it also leads to a deterioration in the overall composition, since the ointment becomes more fluid. Medical Vaseline (GOST 3582-84) is introduced into the composition as a filler.
Предлагаемые композиции иллюстрируются нижеследующими примерами:The proposed composition is illustrated by the following examples:
Пример JYsI. (приготовление эмульсии)JYsI example. (emulsion preparation)
В кругл одонную колбу заливают 12,5 частей деароматизированного белого нафталана, заранее приготовленного 4 частей эмульгатора T1, и доводят до 100 частей заранее приготовленным водным экстрактом лекарственных растений. Колбу помещают на водяную баню и при постоянном перемешивании нагревают при температуре не более 600C в течение 2 часов. Полученная эмульсия имеет бело-зеленоватый цвет с приятным запахом лекарственных растений.12.5 parts of dearomatized white are poured into a round, single flask naphthalan, pre-prepared 4 parts of the emulsifier T 1 , and adjusted to 100 parts with a pre-prepared aqueous extract of medicinal plants. The flask is placed in a water bath and with constant stirring is heated at a temperature of not more than 60 0 C for 2 hours. The resulting emulsion has a white-greenish color with a pleasant smell of medicinal plants.
Примеры N° 2-5 проводят аналогично примеру XsI и сведены в таблицу 1.Examples N ° 2-5 are carried out analogously to example XsI and are summarized in table 1.
Пример Na 6. (приготовление мази)Example Na 6. (preparation of ointment)
В круглодонную колбу заливают 15чacтeй деароматизированного белого нафталана, 2 части заранее приготовленного масляного экстракта лекарственных pacтeний,15 частей заранее растопленного парафина и доводят до 100 частей вазелином. Колбу помещают на водяную баню и при постоянном перемешивании нагревают при температуре не более 600C в течение 2 часов. Полученная мазь имеет кремово-зеленоватый цвет с приятным запахом лекарственных растений. Мазь упаковывают в баночки защищенные от солнечных лучей. Примеры N° 7-8 проводят аналогично примеру N° 6 и сведены в таблицу 2.15 parts of dearomatized white naphthalan, 2 parts of a pre-prepared oil extract of medicinal plants, 15 parts of pre-melted paraffin are poured into a round-bottom flask, and 15 parts of pre-melted paraffin are made up to 100 parts with petroleum jelly. The flask is placed in a water bath and with constant stirring is heated at a temperature of not more than 60 0 C for 2 hours. The resulting ointment has a creamy greenish color with a pleasant smell of medicinal plants. The ointment is packaged in jars protected from sunlight. Examples N ° 7-8 are carried out analogously to example N ° 6 and are summarized in table 2.
Положительным эффектом является то, что помимо того, что предлагаемую композицию можно использовать для массажа, ее также можно использовать в косметических целях.The positive effect is that in addition to the fact that the proposed composition can be used for massage, it can also be used for cosmetic purposes.
ИСТОЧНИКИ ИНФОРМАЦИИ ПРИНЯТЫЕ КО ВНИМАНИЮ: 1. Машковский М.Д. «Лeкapcтвeнныe средства)) часть 2, вып.9, 1984г. стр. 415, изд.Медицина, Москва.SOURCES OF INFORMATION TAKEN TO ATTENTION: 1. Mashkovsky MD “Medicines)) part 2, issue 9, 1984. p. 415, ed.Meditsina, Moscow.
2. там же2. ibid.
3. там же3. ibid.
4. там же. Таблица JМbl4. in the same place. Jbl table
Figure imgf000006_0001
Таблица N° 2
Figure imgf000006_0001
Table N ° 2
Figure imgf000007_0001
Figure imgf000007_0001

Claims

ФОРМУЛА ИЗОБРЕТЕНИЯ CLAIM
1. Композиция на основе нафталанской нефти, содержащая эмульсионную основу, отличающаяся тем, что в качестве нафталанской нефти содержит деароматизированный белый нафталан, а в качестве эмульсионной основы эмульгатор Tj, или T2 и дополнительно, водные экстракты лекарственных растений при следующем соотношении компонентов, мacc.%: деароматизированный белый нафталан - 12,5-30; эмульгатор - 3-7; водные экстракты лекарственных растений- остальное.1. A composition based on naphthalan oil containing an emulsion base, characterized in that as naphthalan oil contains dearomatized white naphthalan, and as an emulsion base emulsifier Tj, or T 2 and additionally, aqueous extracts of medicinal plants in the following ratio of components, macc. %: dearomatized white naphthalan - 12.5-30; emulsifier - 3-7; water extracts of medicinal plants - the rest.
2. Композиция на основе нафталанской нефти, содержащая парафин, о т л и ч а ю щ а я с я тем, что в качестве нафталанской нефти содержит деароматизированный белый нафталан, и дополнительно, вазелин белый медицинский, масляные экстракты лекарственных растений при следующем соотношении компонентов, мacc.% : деароматизированный белый нафталан- 15-45; масляные экcтpaкты-2-б; цapaфин-15-20, вазелин медицинский белый- остальное.2. A composition based on naphthalan oil containing paraffin, with the fact that it contains dearomatized white naphthalan as naphthalan oil, and additionally, white medical vaseline, oil extracts of medicinal plants in the following ratio of components , mass%: dearomatized white naphthalan-15-45; oil extracts-2-b; tsapafin-15-20, medical white petrolatum - the rest.
3. Композиция по п.l или 2, отл ичаю щаяс я тем, что в качестве лекарственных растений для водного или масляного экстрактов содержит ромашку и/или герань, и/или эвкалипт, и/или гвоздику, и/или лаванду, и/или розу, и/или дифазиум, и/или мирт, и/или примулу. 3. The composition according to claim 1 or 2, characterized in that as medicinal plants for water or oil extracts contains chamomile and / or geranium, and / or eucalyptus, and / or cloves, and / or lavender, and / or a rose, and / or diphazium, and / or myrtle, and / or primrose.
PCT/AZ2006/000009 2006-12-27 2006-12-27 Naphthalan oil-based composition WO2008077201A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AZ2006/000009 WO2008077201A1 (en) 2006-12-27 2006-12-27 Naphthalan oil-based composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AZ2006/000009 WO2008077201A1 (en) 2006-12-27 2006-12-27 Naphthalan oil-based composition

Publications (1)

Publication Number Publication Date
WO2008077201A1 true WO2008077201A1 (en) 2008-07-03

Family

ID=39562042

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AZ2006/000009 WO2008077201A1 (en) 2006-12-27 2006-12-27 Naphthalan oil-based composition

Country Status (1)

Country Link
WO (1) WO2008077201A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2460901A (en) * 2008-06-20 2009-12-23 Guy Richard Simon Preston Balm for use in the treatment of percussive injuries, grazes, cuts and burns

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074730C1 (en) * 1993-05-24 1997-03-10 Николай Яковлевич Костеша Ointment for skin diseases treatment: eczema, psoriasis, neurodermatitis
RU2135189C1 (en) * 1999-01-19 1999-08-27 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Soft medicinal form containing refined naphthalane oil and method of its preparing
RU2236860C2 (en) * 2002-11-06 2004-09-27 Саидкадам Мубораккадамович Давляткадамов Ointment "orien" with analgetic and anti-inflammatory effect
RU2004115454A (en) * 2004-05-21 2005-11-10 Дмитрий Васильевич Николенко (RU) COMPOSITION (OPTIONS) AND METHOD FOR TREATING PSORIASIS, ECZEMA, NEURODERMITIS

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074730C1 (en) * 1993-05-24 1997-03-10 Николай Яковлевич Костеша Ointment for skin diseases treatment: eczema, psoriasis, neurodermatitis
RU2135189C1 (en) * 1999-01-19 1999-08-27 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Soft medicinal form containing refined naphthalane oil and method of its preparing
RU2236860C2 (en) * 2002-11-06 2004-09-27 Саидкадам Мубораккадамович Давляткадамов Ointment "orien" with analgetic and anti-inflammatory effect
RU2004115454A (en) * 2004-05-21 2005-11-10 Дмитрий Васильевич Николенко (RU) COMPOSITION (OPTIONS) AND METHOD FOR TREATING PSORIASIS, ECZEMA, NEURODERMITIS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2460901A (en) * 2008-06-20 2009-12-23 Guy Richard Simon Preston Balm for use in the treatment of percussive injuries, grazes, cuts and burns
GB2460901B (en) * 2008-06-20 2012-03-21 Guy Richard Simon Preston Balm

Similar Documents

Publication Publication Date Title
US20070134195A1 (en) Topical Analgesic for Sensitive Skin
EP3247211A1 (en) Microbicidal oil-in-water dispersion
US11564963B2 (en) Topical compositions, process of large-scale manufacture, and method of use
US20080145461A1 (en) Formulation and method of making a topical pain relief composition
Sonalkar et al. Formulation and evaluation of polyherbal cosmetic cream
CA2627021A1 (en) Combination natural source/local anesthetic/dual component penetration enhancer topical formulation useful for treating pain, itching and/or inflammation of the skin
JP2010120909A (en) External application agent, external application cream and external application gel
CA3188531A1 (en) Topical compositions, process of large-scale manufacture, and method of use
DE202005005557U1 (en) Oil or balm for treating rheumatism, gout, sciatica, joint pain and back pain comprises a St John's wort extract, an arnica extract and essential oils
WO2008077201A1 (en) Naphthalan oil-based composition
CA3020457A1 (en) Herbal topical composition for muscle and joint health, recovery from exertion, and for pain management
RU2412719C2 (en) Anti-eczema medication "pro-xylane"
RU2287995C1 (en) Wound-healing preparation (variants)
US20140127315A1 (en) Caudal Salve
EA017050B1 (en) Compositions for prophylaxis and local treatment of inflammatory diseases of skin and also joints and muscles comprising dearomatized white naphthalane
BR102019015537A2 (en) NANOFORMULATION DEVELOPED BASED ON COPAÍBA OIL FOR TOPICAL USE IN LASER ASSOCIATED HEALING PROCESS
RU2301658C1 (en) Biocide cream
US9867775B2 (en) Topical pharmaceutical bases for treating inflammatory disorders
RU2248198C2 (en) Anti-burn preparation
EP3006035A1 (en) Cicatrizing composition for the treatment and resolution of external lesions
DE102005016138A1 (en) Preparation of a natural remedy, useful to cure e.g. bone rheumatism, comprises e.g. lavendulae ethers and eucalyptus ether in the form of herbal oil that is supplemented with sheabutter and beeswax in the form of herbal balm
RO126996B1 (en) Cream for the treatment of anal fissures and process for preparing the same
RU2460513C2 (en) Oil beauty product for care of dry skin
RU2180581C1 (en) Composition for treatment of inflammatory and degenerative diseases of locomotor apparatus
RU2237467C1 (en) Cream for massage

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06840421

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06840421

Country of ref document: EP

Kind code of ref document: A1